InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: kaddy27 post# 130550

Sunday, 06/30/2013 5:34:05 PM

Sunday, June 30, 2013 5:34:05 PM

Post# of 346054
Kaddy27, playing devils advocate is fine and its what should be done to double and triple check that Bavi works well and I've been doing just that for some time now...

"as the fog will be clearing very soon "

just playing devil's advocate here, but, unless there are facts behind that statement, it's just as misleading as the negative ones...


I can understand how some people can say that... but those would be the ones that are brand new to this board and haven't seen all the past posts.

1) "Clear Evidence of dose switching"

2) MOS improvement 109%+ .... conservatively combined to give a still historic 60% MOS improvement

3) FDA approving these clinical trial data and Phase III approved before ASCO 2013.

Thats the meat of it.... that the FDA can see through the fog and its the FDA that matters the most, along with the scientific community. As for the pawn writers and one liners that call out scam/sham and so on... means nothing. I'd love to see more facts from the opposition because then when those facts are squashed it only makes the case that Bavi is moving forward only stronger. Remember Bavi a placebo? Remember Dr. Schwartz? Remember Dr. Jack West? Remember the first post of those few that attack the most against Peregrine? Remember all the posts on Black Monday.. go back and read them! Remember all of it because I hate to say it, but many of them probably have more shares of Peregrine than many of us at this very point.

4) ... but now 14+ months control arm at only 60% ?? You do realize that meant if it was allowed to finish out you'd see a greater than 14+ months control arm.. right? How much more info does one need to see there have been fog machines all over the place from Fargo to who knows where else...

The game is over for them and if it was not over.... the game would be over for the FDA!

There comes a time when if a drug works... the drug works and Bavi works well. There will be winners and losers. This only means that one of the BP's on the losing end has a decision to make if they want to jump on the "immunotherapy" pipeline that has proven to work safely and efficiently. All we need is one BP.

There will be no being spoon fed every single detail as many of us would like... because the information above tells it all.

GLTA!


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News